2027 PRESENTING COMPANIES
DNB Carnegie Back Bay is proud to invite US and Nordic life science companies with exceptional technologies or advances to present at the 11th Annual Nordic-American Healthcare Conference.
Over the years, NAHC presenting companies have showcased cutting-edge technologies designed to address critical unmet needs in disease treatment and significantly advance healthcare delivery.
The following companies will present their healthcare technologies/updates at NAHC 2027:
-

Affibody (Private)
SWEDEN
Radiopharmaceuticals, Development
Company Information -

Bavarian Nordic
DENMARK
Vaccines, Commercial and Development
Company Information -

Bial (Private)
UNITED STATES
Parkinson’s Disease/Epilepsy, Development
Company Information -

BioArctic (BIOA B)
SWEDEN
Neurodegeneration, Commercial and Development
Company Information -

BioGaia (BIOG-B.ST)
SWEDEN
Probiotics, Commercial
Company Information -

BioInvent (BIX0.F)
SWEDEN
Immuno-oncology, Development
Company Information -

Bonesupport (BONEX)
SWEDEN
Orthopedics/Biomaterials, Commercial
Company Information -

Calluna Pharma (Private)
NORWAY
Inflammation/IPF, Development
Company Information -

Camurus (CAMX.ST)
SWEDEN
CNS, Rare Disease, Oncology
Company Information -

Egetis Therapeutics (EGTX.ST)
SWEDEN
Gene-Editing/Rare Disease, Development
Company Info -

F2G (Private)
US-UK
Rare/Fungal, Development
Company Information -

Gubra (GUBRA)
DENMARK
Obesity and Metabolic/CRO, Development
Company Information > -

Hansa BioPharma (HNSA.ST)
SWEDEN
Autoimmune/Immuno-modulation, Development
Company Information -

Ironwood Pharmaceuticals (RWD)
UNITED STATES
Gastrointestinal/rare disease, Commercial and development
Company Information -

Ligand Pharmaceuticals Inc. (LGND)
UNITED STATES
Multiple Biopharma Platforms, Commercial and Development
Company Information -

Lundbeck (HLUN B)
DENMARK
CNS, Commercial and Development
Company Information -

Photocure (PHO)
NORWAY
Bladder Cancer Precision Diagnostics, Commercial
Company Information -

Saniona (SANION.ST)
SWEDEN
CNS, Development
Company Information -

Vicore Pharma (NASDAQ: VCRE)
SWEDEN
Rare Disease/IPF, Development
Company Information -

XVIVO (XVIVO)
SWEDEN
Organ Transplant, Commercial and Development
Company Information

